Medtronic, Inc. Announces First Use of Novel, Interventional Treatment for High Blood Pressure in Latin America

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic today announced the first use in Latin America of renal denervation with the Medtronic Symplicity Catheter System™ to treat a patient with resistant hypertension, which is defined as high blood pressure despite treatment with three or more anti-hypertensive medications. Hypertension is an especially dangerous disease affecting hundreds of millions of people worldwide.

MORE ON THIS TOPIC